Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
Transl Psychiatry ; 7(5): e1115, 2017 05 02.
Article in English | MEDLINE | ID: mdl-28463241

ABSTRACT

A subgroup of individuals with mood and psychotic disorders shows evidence of inflammation that leads to activation of the kynurenine pathway and the increased production of neuroactive kynurenine metabolites. Depression is hypothesized to be causally associated with an imbalance in the kynurenine pathway, with an increased metabolism down the 3-hydroxykynurenine (3HK) branch of the pathway leading to increased levels of the neurotoxic metabolite, quinolinic acid (QA), which is a putative N-methyl-d-aspartate (NMDA) receptor agonist. In contrast, schizophrenia and psychosis are hypothesized to arise from increased metabolism of the NMDA receptor antagonist, kynurenic acid (KynA), leading to hypofunction of GABAergic interneurons, the disinhibition of pyramidal neurons and striatal hyperdopaminergia. Here we present results that challenge the model of excess KynA production in affective psychosis. After rigorous control of potential confounders and multiple testing we find significant reductions in serum KynA and/or KynA/QA in acutely ill inpatients with major depressive disorder (N=35), bipolar disorder (N=53) and schizoaffective disorder (N=40) versus healthy controls (N=92). No significant difference was found between acutely ill inpatients with schizophrenia (n=21) and healthy controls. Further, a post hoc comparison of patients divided into the categories of non-psychotic affective disorder, affective psychosis and psychotic disorder (non-affective) showed that the greatest decrease in KynA was in the affective psychosis group relative to the other diagnostic groups. Our results are consistent with reports of elevations in proinflammatory cytokines in psychosis, and preclinical work showing that inflammation upregulates the enzyme, kynurenine mono-oxygenase (KMO), which converts kynurenine into 3-hydroxykynurenine and quinolinic acid.


Subject(s)
Affective Disorders, Psychotic/metabolism , Kynurenic Acid/blood , Kynurenine 3-Monooxygenase/metabolism , Adult , Affective Disorders, Psychotic/blood , Affective Disorders, Psychotic/physiopathology , Bipolar Disorder/metabolism , Corpus Striatum/metabolism , Cytokines/metabolism , Depression/metabolism , Depressive Disorder, Major/metabolism , Female , GABAergic Neurons/metabolism , Humans , Inflammation/enzymology , Kynurenic Acid/metabolism , Kynurenine/analogs & derivatives , Kynurenine/metabolism , Male , Middle Aged , Psychotic Disorders/metabolism , Quinolinic Acid/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism , Schizophrenia/metabolism
2.
Transl Psychiatry ; 6(11): e946, 2016 11 08.
Article in English | MEDLINE | ID: mdl-27824355

ABSTRACT

A proportion of cases with mood disorders have elevated inflammatory markers in the blood that conceivably may result from stress, infection and/or autoimmunity. However, it is not yet clear whether depression is a neuroinflammatory disease. Multiple histopathological and molecular abnormalities have been found postmortem but the etiology of these abnormalities is unknown. Here, we take an immunological perspective of this literature. Increases in activated microglia or perivascular macrophages in suicide victims have been reported in the parenchyma. In contrast, astrocytic markers generally are downregulated in mood disorders. Impairment of astrocytic function likely compromises the reuptake of glutamate potentially leading to excitotoxicity. Inflammatory cytokines and microglia/macrophage-derived quinolinic acid (QA) downregulate the excitatory amino acid transporters responsible for this reuptake, while QA has the additional effect of inhibiting astroglial glutamine synthetase, which converts glutamate to glutamine. Given that oligodendroglia are particularly vulnerable to inflammation, it is noteworthy that reductions in numbers or density of oligodendrocyte cells are one of the most prominent findings in depression. Structural and/or functional changes to GABAergic interneurons also are salient in postmortem brain samples, and may conceivably be related to early inflammatory insults. Although the postmortem data are consistent with a neuroimmune etiology in a subgroup of depressed individuals, we do not argue that all depression-associated abnormalities are reflective of a neuroinflammatory process or even that all immunological activity in the brain is deleterious. Rather, we highlight the pervasive role of immune signaling pathways in brain function and provide an alternative perspective on the current postmortem literature.


Subject(s)
Bipolar Disorder/immunology , Bipolar Disorder/pathology , Brain/immunology , Brain/pathology , Depressive Disorder, Major/immunology , Depressive Disorder, Major/pathology , Inflammation Mediators/metabolism , Inflammation/immunology , Inflammation/pathology , Astrocytes/immunology , Astrocytes/pathology , Autoimmune Diseases of the Nervous System/immunology , Autoimmune Diseases of the Nervous System/pathology , Humans , Interneurons/immunology , Interneurons/pathology , Microglia/immunology , Microglia/pathology , Neurons/immunology , Neurons/pathology , Oligodendroglia/immunology , Oligodendroglia/pathology , Stress, Psychological/complications , Stress, Psychological/immunology , Suicide/psychology , gamma-Aminobutyric Acid/metabolism
4.
Mol Psychiatry ; 18(5): 528-39, 2013 May.
Article in English | MEDLINE | ID: mdl-23546169

ABSTRACT

In response to queries about whether brain imaging technology has reached the point where it is useful for making a clinical diagnosis and for helping to guide treatment selection, the American Psychiatric Association (APA) has recently written a position paper on the Clinical Application of Brain Imaging in Psychiatry. The following perspective piece is based on our contribution to this APA position paper, which specifically emphasized the application of neuroimaging in mood disorders. We present an introductory overview of the challenges faced by researchers in developing valid and reliable biomarkers for psychiatric disorders, followed by a synopsis of the extant neuroimaging findings in mood disorders, and an evidence-based review of the current research on brain imaging biomarkers in adult mood disorders. Although there are a number of promising results, by the standards proposed below, we argue that there are currently no brain imaging biomarkers that are clinically useful for establishing diagnosis or predicting treatment outcome in mood disorders.


Subject(s)
Brain/pathology , Mood Disorders/diagnosis , Neuroimaging , Biomarkers/metabolism , Brain/diagnostic imaging , Evidence-Based Medicine , Humans , Neuroimaging/methods , Neuroimaging/standards , Radionuclide Imaging , Reproducibility of Results , United States , United States Food and Drug Administration
5.
Transl Psychiatry ; 2: e154, 2012 Aug 14.
Article in English | MEDLINE | ID: mdl-22892719

ABSTRACT

Most pathway and gene-set enrichment methods prioritize genes by their main effect and do not account for variation due to interactions in the pathway. A portion of the presumed missing heritability in genome-wide association studies (GWAS) may be accounted for through gene-gene interactions and additive genetic variability. In this study, we prioritize genes for pathway enrichment in GWAS of bipolar disorder (BD) by aggregating gene-gene interaction information with main effect associations through a machine learning (evaporative cooling) feature selection and epistasis network centrality analysis. We validate this approach in a two-stage (discovery/replication) pathway analysis of GWAS of BD. The discovery cohort comes from the Wellcome Trust Case Control Consortium (WTCCC) GWAS of BD, and the replication cohort comes from the National Institute of Mental Health (NIMH) GWAS of BD in European Ancestry individuals. Epistasis network centrality yields replicated enrichment of Cadherin signaling pathway, whose genes have been hypothesized to have an important role in BD pathophysiology but have not demonstrated enrichment in previous analysis. Other enriched pathways include Wnt signaling, circadian rhythm pathway, axon guidance and neuroactive ligand-receptor interaction. In addition to pathway enrichment, the collective network approach elevates the importance of ANK3, DGKH and ODZ4 for BD susceptibility in the WTCCC GWAS, despite their weak single-locus effect in the data. These results provide evidence that numerous small interactions among common alleles may contribute to the diathesis for BD and demonstrate the importance of including information from the network of gene-gene interactions as well as main effects when prioritizing genes for pathway analysis.


Subject(s)
Bipolar Disorder/genetics , Cadherins/genetics , Epistasis, Genetic , Gene Regulatory Networks , Genome-Wide Association Study/methods , Algorithms , Artificial Intelligence , Cohort Studies , Genetic Predisposition to Disease , Genetic Variation , Humans , Linear Models , Polymorphism, Single Nucleotide
6.
Mol Psychiatry ; 16(4): 407-18, 2011 Apr.
Article in English | MEDLINE | ID: mdl-20351719

ABSTRACT

Genetic variation in the cholinergic muscarinic-2 (M(2)) receptor gene (CHRM2) has been associated with the risk for developing depression. We previously reported that M(2)-receptor distribution volume (V(T)) was reduced in depressed subjects with bipolar disorder (BD) relative to depressed subjects with major depressive disorder (MDD) and healthy controls (HCs). In this study, we investigated the effects of six single-nucleotide polymorphisms (SNPs) for CHRM2 on M(2)-receptor binding to test the hypotheses that genetic variation in CHRM2 influences M(2)-receptor binding and that a CHRM2 polymorphism underlies the deficits in M(2)-receptor V(T) observed in BD. The M(2)-receptor V(T) was measured using positron emission tomography and [(18)F]FP-TZTP in unmedicated, depressed subjects with BD (n=16) or MDD (n=24) and HCs (n=25), and the effect of genotype on V(T) was assessed. In the controls, one SNP (with identifier rs324650, in which the ancestral allele adenine (A) is replaced with one or two copies of thymine (T), showed a significant allelic effect on V(T) in the pregenual and subgenual anterior cingulate cortices in the direction AA

Subject(s)
Bipolar Disorder/genetics , Brain/diagnostic imaging , Brain/metabolism , Polymorphism, Single Nucleotide/genetics , Receptor, Muscarinic M2/genetics , Receptor, Muscarinic M2/metabolism , Adolescent , Adult , Bipolar Disorder/complications , Bipolar Disorder/diagnostic imaging , Cognition Disorders/diagnosis , Cognition Disorders/etiology , Female , Fluorine Radioisotopes , Genome-Wide Association Study , Genotype , Humans , Male , Middle Aged , Neuropsychological Tests , Positron-Emission Tomography/methods , Protein Binding/drug effects , Protein Binding/genetics , Psychiatric Status Rating Scales , Statistics, Nonparametric , Young Adult
7.
CNS Spectr ; 14(3): 122-6, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19407708

ABSTRACT

Bipolar disorder is clinically characterized by fluctuating affect, and neuropsychologically by impairment in executive functions. Such phenomena are consistent with the centrality of emotional dysregulation and impulsivity to bipolar disorder. They are also consistent with a key role for prefrontal-subcortical (striatal-thalamic) and associated limbic circuitry in its mediation. Furthermore, there is growing data on the cellular mechanisms contributing to neuronal vulnerability in this mediating circuitry.


Subject(s)
Bipolar Disorder/pathology , Bipolar Disorder/psychology , Emotions/physiology , Neurons/pathology , Bipolar Disorder/metabolism , Brain Chemistry , Female , Humans , Magnetic Resonance Imaging , Psychiatric Status Rating Scales , Young Adult
8.
Neuroscience ; 164(1): 300-30, 2009 Nov 24.
Article in English | MEDLINE | ID: mdl-19358877

ABSTRACT

Imaging techniques are a potentially powerful method of identifying phenotypes that are associated with, or are indicative of, a vulnerability to developing major depressive disorder (MDD). Here we identify seven promising MDD-associated traits identified by magnetic resonance imaging (MRI) or positron emission tomography (PET). We evaluate whether these traits are state-independent, heritable endophenotypes, or state-dependent phenotypes that may be useful markers of treatment efficacy. In MDD, increased activity of the amygdala in response to negative stimuli appears to be a mood-congruent phenomenon, and is likely moderated by the 5-HT transporter gene (SLC6A4) promoter polymorphism (5-HTTLPR). Hippocampal volume loss is characteristic of elderly or chronically-ill samples and may be impacted by the val66met brain-derived neurotrophic factor (BDNF) gene variant and the 5-HTTLPR SLC6A4 polymorphism. White matter pathology is salient in elderly MDD cohorts but is associated with cerebrovascular disease, and is unlikely to be a useful marker of a latent MDD diathesis. Increased blood flow or metabolism of the subgenual anterior cingulate cortex (sgACC), together with gray matter volume loss in this region, is a well-replicated finding in MDD. An attenuation of the usual pattern of fronto-limbic connectivity, particularly a decreased temporal correlation in amygdala-anterior cingulate cortex (ACC) activity, is another MDD-associated trait. Concerning neuroreceptor PET imaging, decreased 5-HT(1A) binding potential in the raphe, medial temporal lobe, and medial prefrontal cortex (mPFC) has been strongly associated with MDD, and may be impacted by a functional single nucleotide polymorphism in the promoter region of the 5-HT(1A) gene (HTR1A: -1019 C/G; rs6295). Potentially indicative of inter-study variation in MDD etiology or mood state, both increased and decreased binding potential of the 5-HT transporter has been reported. Challenges facing the field include the problem of phenotypic and etiological heterogeneity, technological limitations, the confounding effects of medication, and non-disease related inter-individual variation in brain morphology and function. Further advances are likely as epigenetic, copy-number variant, gene-gene interaction, and genome-wide association (GWA) approaches are brought to bear on imaging data.


Subject(s)
Depressive Disorder, Major/genetics , Depressive Disorder, Major/physiopathology , Phenotype , Animals , Brain/diagnostic imaging , Brain/pathology , Brain/physiopathology , Brain Mapping , Depressive Disorder, Major/diagnostic imaging , Depressive Disorder, Major/pathology , Humans , Models, Genetic , Radionuclide Imaging
9.
Genes Brain Behav ; 7(8): 869-76, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18826446

ABSTRACT

Genetic analyses of complex conditions such as bipolar disorder (BD) may be facilitated by the use of intermediate phenotypes. Various personality traits are overrepresented in people with BD and their unaffected relatives, and may constitute genetically transmitted risk factors or endophenotypes of the illness. In this study, we administered a battery of seven different personality questionnaires comprising 19 subscales to 31 Caucasian BD families (n = 241). Ten of these personality traits showed significant evidence of heritability and were therefore selected as candidate endophenotypes. In addition, a principal components analysis produced two heritable components (negative affect and appetitive drive), which accounted for a considerable proportion of the variance (29% + 12%) and were also used in the analysis. A family-based quantitative association study was carried out using the orthogonal model from the quantitative transmission disequilibrium tests (QTDT) program. Monte Carlo permutations (M = 500), which allow for non-normal data and provide a global P value, corrected for multiple testing, were used to calculate empirical P values for the within-family component of association. The 3' untranslated region repeat polymorphism of the dopamine transporter gene (SLC6A3) was associated with self-directedness (P < 0.0001) and negative affect (P = 0.010). The short allele of the serotonin transporter gene (SLC6A4) promoter polymorphism showed a trend toward association with higher harm avoidance (P = 0.016) and negative affect (P = 0.028). The catechol-o-methyltransferase val158met polymorphism was weakly associated with the personality traits, 'Spirituality' (P = 0.040) and irritable temperament (P = 0.022). Furthermore, the met allele of the brain-derived neurotrophic factor val66met polymorphism was associated with higher hyperthymic temperament scores. We raise the possibility that the 10R allele of the SLC6A3 repeat polymorphism and the short allele of the SLC6A4 promoter variant constitute risk factors for irritable-aggressive and anxious-dysthymic subtypes of BD, respectively.


Subject(s)
Bipolar Disorder/genetics , Genetic Predisposition to Disease/genetics , Inheritance Patterns/genetics , Personality/genetics , Adult , Aged , Bipolar Disorder/metabolism , Bipolar Disorder/physiopathology , Catechol O-Methyltransferase/genetics , Cohort Studies , Dopamine Plasma Membrane Transport Proteins/genetics , Family/psychology , Female , Gene Frequency/genetics , Genome-Wide Association Study , Humans , Linkage Disequilibrium/genetics , Male , Middle Aged , Personality Inventory , Phenotype , Polymorphism, Genetic/genetics , Principal Component Analysis , Serotonin Plasma Membrane Transport Proteins/genetics , Surveys and Questionnaires , Temperament/physiology
10.
Genes Brain Behav ; 6(8): 698-705, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17309660

ABSTRACT

Diverse strands of evidence suggest that schizophrenia is associated with an excess of left and mixed handedness, reflecting anomalous cerebral lateralization. Genetic studies have indicated a degree of overlap between bipolar disorder (BPD) and schizophrenia. Nevertheless, pattern of handedness and degree of lateralization have not been explicitly tested in BPD. We measured handedness, footedness and relative manual dexterity in a sample of 47 families comprising BPD probands and their bipolar-spectrum and unaffected relatives (N = 240). The BPD I sample (N = 55) was significantly more lateralized on handedness, footedness and relative manual dexterity than their unaffected relatives (N = 66). They were also more lateralized than their relatives with other psychiatric diagnoses. No evidence of excess mixed handedness or footedness was observed in the BPD I sample. We raise the possibility that schizophrenia and BPD I differ in that disproportionate left-hemisphere dominance in BPD I is associated with right-hemisphere dysfunction leading to deficits in emotional regulation. Given our results, we hypothesized that degree of lateralization may be a phenotypic marker or endophenotype for BPD I. We therefore conducted a family-based genetic association analysis with this quantitative trait. Relative hand skill was significantly associated with a functional variant in the catechol-O-methyltransferase gene. We speculate that this polymorphism may influence brain lateralization.


Subject(s)
Bipolar Disorder/physiopathology , Catechol O-Methyltransferase/genetics , Functional Laterality/genetics , Motor Skills/physiology , Adolescent , Adult , Aged , Aged, 80 and over , Bipolar Disorder/genetics , Case-Control Studies , Catechol O-Methyltransferase/physiology , Family , Female , Foot/physiology , Hand/physiology , Humans , Male , Middle Aged , Pedigree , Statistics, Nonparametric
11.
Genes Brain Behav ; 5(4): 311-28, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16716201

ABSTRACT

The important contribution of genetic factors to the development of cognition and intelligence is widely acknowledged, but identification of these genes has proven to be difficult. Given a variety of evidence implicating the prefrontal cortex and its dopaminergic circuits in cognition, most of the research conducted to date has focused on genes regulating dopaminergic function. Here we review the genetic association studies carried out on catechol-O-methyltransferase (COMT) and the dopamine receptor genes, D1, D2 and D4. In addition, the evidence implicating another promising candidate gene, brain-derived neurotrophic factor (BDNF) in neuropsychological function, is assessed. Both the COMT val158met polymorphism and the BDNF val66met variant appear to influence cognitive function, but the specific neurocognitive processes involved continue to be a matter of debate. Part of the difficulty is distinguishing between false positives, pleiotropy and the influence of a general intelligence factor, g. Also at issue is the complexity of the relevant neuromolecular pathways, which make the inference of simple causal relationships difficult. The implications of molecular genetic cognitive research for psychiatry are discussed in light of these data.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , Catechol O-Methyltransferase/metabolism , Cognition Disorders/genetics , Cognition Disorders/metabolism , Cognition/physiology , Dopamine/metabolism , Animals , Brain-Derived Neurotrophic Factor/genetics , Catechol O-Methyltransferase/genetics , Dopamine/genetics , Gene Expression Regulation/physiology , Humans , Molecular Biology , Polymorphism, Genetic , Prefrontal Cortex/metabolism , Receptors, Dopamine/classification , Receptors, Dopamine/genetics , Receptors, Dopamine/metabolism
12.
J Genet Psychol ; 164(3): 319-33, 2003 Sep.
Article in English | MEDLINE | ID: mdl-14521215

ABSTRACT

The performance on the Stroop Color-Word Interference Test of 36 boys with Attention Deficit Hyperactivity Disorder (ADHD) was compared with performances of a matched control sample. The control group outperformed their counterparts on the control and interference conditions of the Stroop test, suggesting ADHD-specific executive and reading deficits. When individuals with both ADHD and reading disorders were excluded from the analysis, the authors found a significant difference between the ADHD group and the control group on the color-word test, indicating that poor reading skills may produce false negatives on the Stroop test. However, fast and slow readers with ADHD did not perform differently from each other on the color-word test. The authors postulated the existence of two different causes of reading problems: phonological deficits and attentional deficits.


Subject(s)
Attention Deficit Disorder with Hyperactivity/diagnosis , Attention Deficit Disorder with Hyperactivity/epidemiology , Color Perception/physiology , Dyslexia/epidemiology , Surveys and Questionnaires , Vocabulary , Attention , Child , Cognition , Comorbidity , Dyslexia/rehabilitation , Humans , Intelligence , Male , Neuropsychological Tests , Phonetics , Prevalence , Remedial Teaching
13.
Ecotoxicology ; 5(1): 47-58, 1996 Feb.
Article in English | MEDLINE | ID: mdl-24193508

ABSTRACT

: The insect growth regulator diflubenzuron (DFB) may have substantial effects on non-target organisms, especially crustaceans. By targeting the moulting process, DFB would be expected to elicit the most obvious effects on subadult crustaceans which moult frequently. Previous studies in this laboratory have demonstrated acute and chronic effects of DFB on survival and development of nauplii of the estuarine copepod Eurytemora affinis at water concentrations of less than 1 p.p.b. The present study examines the effects on maturation to adulthood and brood production. Effects on brood production were observed at 0.8 p.p.b. DFB in individuals exposed only during the copepodite stages. Significant effects on production of nauplii were documented only in the early exposure to 0.93 p.p.b. DFB. Inability of post-moult copepodites to completely cast exuviae also was documented in the exposed treatments. At salinities of 2, 10 and 15 p.p.t., survival from naupliar to adult stages was significantly reduced at 0.84 p.p.b. and none survived to adulthood at 1.7 p.p.b. These results suggest that DFB has substantial effects on survival and development of E. affinis at a water concentration of less than 1 p.p.b. DFB concentrations exceeding this concentration have been reported from Chesapeake Bay surface waters although there is no current evidence of potentially toxic concentrations overlapping with the known distribution of E. affinis in the bay.

14.
Stroke ; 25(1): 214-6, 1994 Jan.
Article in English | MEDLINE | ID: mdl-8266371

ABSTRACT

BACKGROUND AND PURPOSE: Stroke is an uncommon sequela of Wegener's granulomatosis, resulting primarily from vasculitic infiltration of small to medium-sized vessels. We describe a young patient with Wegener's granulomatosis and basilar artery occlusion. CASE DESCRIPTION: A 26-year-old man with histopathologically confirmed Wegener's granulomatosis suffered a brain stem stroke 24 hours after open lung biopsy. Angiography revealed midbasilar artery occlusion. CONCLUSIONS: Patients with Wegener's granulomatosis may experience premature large cerebral vessel occlusion. Putative etiologies in our patient include vasculitis, postoperative hypercoagulability, and/or intraoperative neck positioning leading to embolization.


Subject(s)
Arterial Occlusive Diseases/etiology , Basilar Artery , Granulomatosis with Polyangiitis/complications , Adult , Biopsy , Brain Stem , Cerebral Angiography , Cerebrovascular Disorders/etiology , Humans , Lung/pathology , Male , Postoperative Complications , Vertebral Artery/diagnostic imaging
15.
Nurs Res ; 30(1): 16-20, 1981.
Article in English | MEDLINE | ID: mdl-6906009

ABSTRACT

An interview schedule to determine whether individuals could be diagnosed psychologically as being in a bored, confused, or adaptive state of mind was constructed and tested. Boredom and confusion were viewed as two distinct maladaptive states of mind. Objectivity, reliability, and validity were demonstrated for the interview schedule. The schedule was effective in diagnosing maladaptive and adaptive states of mind in outpatients who sought help at a family practice clinic and in detecting changes from maladaptive states to an adaptive state of mind after four weeks of psychological treatment.


Subject(s)
Adaptation, Psychological , Boredom , Cognition Disorders/diagnosis , Confusion/diagnosis , Interview, Psychological , Adolescent , Adult , Humans , Middle Aged , Outpatients
SELECTION OF CITATIONS
SEARCH DETAIL
...